Kiora Pharmaceuticals, Inc. (KPRX) NASDAQ
2.06
+0.02(+0.98%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.06
+0.02(+0.98%)
Currency In USD
| Market Cap | 12.78M |
| Enterprise Value | 9.04M |
| P/E Ratio | -1.03 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.39 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.27 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.29 |
| Return On Equity | -0.36 |
| Revenue | 16M |
| Revenue/Share | 0 |
| Gross Profit | 16M |
| EBITDA | 5.7M |
| Net Income | 3.59M |
| Diluted EPS | 0.87 |
| Total Cash | 19.38M |
| Total Cash/Share | 4.52 |
| Total Debt | 404,165 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 8.79 |
| Book Value Per Share | 5.22 |
| 52-Week Change | -35.63 |
| 52-Week High | 4.18 |
| 52-Week Low | 1.77 |
| Moving Average 50 Days | 2.13 |
| Moving Average 200 Days | 2.46 |
| Average Volume | 47,361 |
| Shares Outstanding | 3.68M |
| % Held by Institutions | 1.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | June 11, 2024 |